Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

4.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.7K
Hematopoiesis01:21

Hematopoiesis

5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

490
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
490
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Lineage Commitment01:21

Lineage Commitment

3.1K
Commitment is the  process whereby stem cells:
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Advances in Superlattice-Based Thermoelectrics.

ACS applied materials & interfaces·2026
Same author

An AI-driven fire risk forecasting framework for urban villages using IGWO-optimized LSTM with incremental learning.

PloS one·2026
Same author

WTConv-TimesNet for Road Icing State Classification with IWOA-Based Hyperparameter Optimization.

Sensors (Basel, Switzerland)·2026
Same author

Age-period-cohort decomposition and projections of the frailty index among older adults in China.

Frontiers in public health·2026
Same author

Treatment Response and Prognosis of Primary Angiitis of the Central Nervous System: A Real-World Observation.

CNS neuroscience & therapeutics·2026
Same author

PPARα-CD36-CAV1-mediated docosahexaenoic acid (DHA) uptake promotes muscle fiber development in grass carp (<i>Ctenopharyngodon idellus</i>).

Animal nutrition (Zhongguo xu mu shou yi xue hui)·2026

Related Experiment Video

Updated: Sep 7, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K

Bone marrow hematopoiesis drives multiple sclerosis progression.

Kaibin Shi1, Handong Li2, Ting Chang3

  • 1Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin 300052, China; Center for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

Cell
|June 16, 2022
PubMed
Summary
This summary is machine-generated.

In multiple sclerosis (MS), bone marrow stem cells shift toward myeloid production, increasing inflammatory cells that enter the central nervous system (CNS). Targeting the bone marrow may offer new treatments for MS.

Keywords:
autoreactive T cellsbone marrowmultiple sclerosismyelopoiesisneuroinflammation

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.4K
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

533

Related Experiment Videos

Last Updated: Sep 7, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.4K
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

533

Area of Science:

  • Immunology
  • Neuroscience
  • Hematology

Background:

  • Multiple sclerosis (MS) is a T cell-mediated autoimmune disease affecting the central nervous system (CNS).
  • The role of bone marrow hematopoietic stem and progenitor cells (HSPCs) in MS pathogenesis is not well understood.
  • HSPCs are known to respond to immune activation.

Purpose of the Study:

  • To investigate the interplay between autoreactive T cells and bone marrow HSPCs in MS.
  • To explore the mechanisms driving aberrant myelopoiesis in the bone marrow of MS patients.
  • To determine if targeting the bone marrow niche can impact CNS inflammation in MS.

Main Methods:

  • Analysis of HSPC lineage skewing and T cell expansion in MS patients.
  • Lineage tracing in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
  • Investigation of cellular migration pathways (e.g., CXCR4) and signaling axes (e.g., CCL5-CCR5) in the bone marrow.

Main Results:

  • Bone marrow HSPCs in MS patients show a myeloid lineage bias with clonal T cell expansion.
  • EAE mice exhibit increased bone marrow myelopoiesis, producing neutrophils and Ly6Chigh monocytes that infiltrate the CNS.
  • Myelin-reactive T cells migrate to the bone marrow via CXCR4, and the CCL5-CCR5 axis drives myelopoiesis, exacerbating CNS inflammation and demyelination.

Conclusions:

  • Aberrant bone marrow myelopoiesis, driven by T cell interactions, contributes to CNS pathology in MS.
  • The bone marrow niche plays a critical role in MS pathogenesis.
  • Targeting the bone marrow microenvironment presents a potential therapeutic strategy for MS and other autoimmune diseases.